Comparison of bone marrow and peripheral blood stem cells as graft source in children undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies with unmanipulated haploidentical grafts utilizing post-transplant cyclophosphamide as GvHD prophylaxis.
Study #: PC23-02
Study Status: Protocol Development